Janko Rakic

751 total citations
18 papers, 488 citations indexed

About

Janko Rakic is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Physiology. According to data from OpenAlex, Janko Rakic has authored 18 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 5 papers in Epidemiology and 5 papers in Physiology. Recurrent topics in Janko Rakic's work include Chronic Obstructive Pulmonary Disease (COPD) Research (13 papers), Respiratory Support and Mechanisms (7 papers) and Asthma and respiratory diseases (4 papers). Janko Rakic is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (13 papers), Respiratory Support and Mechanisms (7 papers) and Asthma and respiratory diseases (4 papers). Janko Rakic collaborates with scholars based in Switzerland, Greece and Spain. Janko Rakic's co-authors include Daiana Stolz, Martin Siegemund, Hans Pargger, Philippe Eggimann, Nicholas A. Smyrnios, Lucas Boeck, Stephan Märsch, M. Tamm, Andrea Azzola and Beat Müeller and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, CHEST Journal and European Respiratory Journal.

In The Last Decade

Janko Rakic

18 papers receiving 476 citations

Peers

Janko Rakic

EPIDE

CCICM

PRM

AMB

SURGE

G. Neeser Germany

Sven Giersdorf Switzerland

Gopal Taori Australia

Lin M. Riccio United States

Dominique Page United States

Yunbo Sun China

Paris Zygoulis Greece

Irini Mavrou Greece

Devendra Amin United States

Hans Kieft Netherlands

G. Neeser Germany

Janko Rakic

295 ×1.0

EPIDE

220 ×1.0

CCICM

98 ×0.5

PRM

29 ×0.4

AMB

61 ×1.1

SURGE

Citations per year, relative to Janko Rakic Janko Rakic (= 1×) peers G. Neeser

Countries citing papers authored by Janko Rakic

Since Specialization

Citations

This map shows the geographic impact of Janko Rakic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janko Rakic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janko Rakic more than expected).

Fields of papers citing papers by Janko Rakic

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janko Rakic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janko Rakic. The network helps show where Janko Rakic may publish in the future.

Co-authorship network of co-authors of Janko Rakic

This figure shows the co-authorship network connecting the top 25 collaborators of Janko Rakic. A scholar is included among the top collaborators of Janko Rakic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janko Rakic. Janko Rakic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Stolz, Daiana, Hans H. Hirsch, Daniel Schilter, et al.. (2017). Intensified Therapy with Inhaled Corticosteroids and Long-Acting β2-Agonists at the Onset of Upper Respiratory Tract Infection to Prevent Chronic Obstructive Pulmonary Disease Exacerbations. A Multicenter, Randomized, Double-Blind, Placebo-controlled Trial. American Journal of Respiratory and Critical Care Medicine. 197(9). 1136–1146. 24 indexed citations

Mandal, Jyotshna, Michael Roth, Eleni Papakonstantinou, et al.. (2017). Treatment with long acting muscarinic antagonists stimulates serum levels of irisin in patients with COPD. Pulmonary Pharmacology & Therapeutics. 48. 111–116. 4 indexed citations

Papakonstantinou, Eleni, Michael Roth, Francesco Blasi, et al.. (2017). Hyaluronic acid, heparan sulfate and chondroitin sulfate are altered during exacerbations of COPD. PA994–PA994. 1 indexed citations

Blum, C, et al.. (2017). Acute-Onset Panhypopituitarism Nearly Missed by Initial Cosyntropin Testing. Case Reports in Critical Care. 2017. 1–4. 2 indexed citations

Papakonstantinou, Eleni, Branislava Milenković, Alícia Lacoma, et al.. (2016). Therapy with proton‐pump inhibitors for gastroesophageal reflux disease does not reduce the risk for severe exacerbations in COPD. Respirology. 21(5). 883–890. 26 indexed citations

Papakonstantinou, Eleni, George Karakiulakis, Michael Roth, et al.. (2016). Hyaluronic acid as a novel systemic biomarker to predict progression and severity in chronic obstructive pulmonary disease. PA4020–PA4020. 1 indexed citations

Mandal, Jyotshna, Michael Roth, Luigi Costa, et al.. (2015). Vasoactive Intestinal Peptide for Diagnosing Exacerbation in Chronic Obstructive Pulmonary Disease. Respiration. 90(5). 357–368. 14 indexed citations

Stolz, Daiana, Jacob Hull Kristensen, Diana Julie Leeming, et al.. (2015). LATE-BREAKING ABSTRACT: Biomarkers of ECM turnover and clinical relevant outcomes in COPD: Results of the multicenter PROMISE study. OA1963–OA1963. 1 indexed citations

Stolz, Daiana, Renaud Louis, Wim Boersma, et al.. (2014). COPD-specific co-morbidity test (COTE) for predicting mortality in COPD – Results of an European, multicenter study. European Respiratory Journal. 44(Suppl 58). P566–P566. 3 indexed citations

10.

Stolz, Daiana, Wim Boersma, Francesco Blasi, et al.. (2014). Exertional Hypoxemia in Stable COPD Is Common and Predicted by Circulating Proadrenomedullin. CHEST Journal. 146(2). 328–338. 22 indexed citations

11.

Stolz, Daiana, et al.. (2014). Mortality risk prediction in COPD by a prognostic biomarker panel. European Respiratory Journal. 44(6). 1557–1570. 33 indexed citations

12.

Stolz, Daiana, Κonstantinos Κostikas, Francesco Blasi, et al.. (2013). Adrenomedullin refines mortality prediction by the BODE index in COPD: the “BODE-A” index. European Respiratory Journal. 43(2). 397–408. 33 indexed citations

13.

Stolz, Daiana, Κonstantinos Κostikas, Francesco Blasi, et al.. (2012). Combined assessment according to the new GOLD guidelines and its relation to outcome in COPD. 40. 1648. 1 indexed citations

14.

Stolz, Daiana, Wim Boersma, Branislava Milenković, et al.. (2012). Proadrenomedullin improves the prognostic property of the BODE index. 40. 1686. 1 indexed citations

15.

Boeck, Lucas, Philippe Eggimann, Nicholas A. Smyrnios, et al.. (2011). The Sequential Organ Failure Assessment score and copeptin for predicting survival in ventilator-associated pneumonia. Journal of Critical Care. 27(5). 523.e1–523.e9. 28 indexed citations

16.

Boeck, Lucas, Rolf Graf, Philippe Eggimann, et al.. (2011). Pancreatic Stone Protein. CHEST Journal. 140(4). 925–932. 42 indexed citations

17.

Boeck, Lucas, Philippe Eggimann, Nicholas A. Smyrnios, et al.. (2010). Midregional pro-atrial natriuretic peptide and procalcitonin improve survival prediction in VAP. European Respiratory Journal. 37(3). 595–603. 22 indexed citations

18.

Stolz, Daiana, Nicholas A. Smyrnios, Philippe Eggimann, et al.. (2009). Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study. European Respiratory Journal. 34(6). 1364–1375. 230 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact